PTC Therapeutics, Inc. Number of Reporting Units
PTC Therapeutics, Inc. (PTCT) reported Number of Reporting Units of 1 item for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-02-19
- PTC Therapeutics, Inc. number of reporting units for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- PTC Therapeutics, Inc. number of reporting units for the quarter ending 2024-03-31 was 1.00 segment.
- PTC Therapeutics, Inc. number of reporting units for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- PTC Therapeutics, Inc. number of reporting units for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- PTC Therapeutics, Inc. number of reporting units for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
- PTC Therapeutics, Inc. number of reporting units for fiscal 2021 was 1.00 segment, a 0.00% change from fiscal 2020.
segment
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-22 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-25 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-02 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-03-01 |
item
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2025-12-31 | 1.00 item 10-K · filed 2026-02-19 |
| 2024-12-31 | 1.00 item 10-K · filed 2025-02-27 |
| 2023-12-31 | 1.00 item 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |